Abstract

Investigators in the Urologic Oncology Branch of the National Cancer Institute are the urologic surgeons and general urology consultants to the entire National Institutes of Health. In this role we see patients in consultation for all pediatric and adult urologic surgical problems. The Urologic Oncology Branch answers all emergency, as well as elective urologic surgical consultations and provides 24 hour coverage for urologic surgical emergencies that may arise in the Clinical Center Hospital. Increasing surgery in AIDS patients is being performed. The Urologic Oncology Branch also collaborates in the procurement of tissue for studies required by other investigative units. The degree of involvement of the Urologic Oncology Branch in the planning and execution of these studies is variable. The Urologic Oncology Branch often plays an instrumental role in the design of these studies while in other collaborations, the Urologic Surgical Service merely provides tissue. Approximately 30% of the clinical surgical effort of the Urologic Oncology Branch is devoted to these consultative and collaborative studies.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Support Services Intramural Research (ZID)
Project #
1ZIDBC011092-06
Application #
8763807
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2013
Total Cost
$3,061,855
Indirect Cost

  Institution

Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code

  Publications

Shuch, Brian; Ricketts, Christopher J; Vocke, Cathy D et al. (2013) Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol 190:1990-8
Shankavaram, Uma; Fliedner, Stephanie M J; Elkahloun, Abdel G et al. (2013) Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas. Neoplasia 15:435-47
Turkbey, Baris; Mani, Haresh; Aras, Omer et al. (2013) Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268:144-52
Shuch, Brian; Ricketts, Christopher J; Vocke, Cathy D et al. (2013) Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol 189:430-5
Boris, Ronald S; Gupta, Gopal N; Benson, Jonas S et al. (2013) Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol 27:196-201
Turcotte, Simon; Turkbey, Baris; Barak, Stephanie et al. (2012) von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms. Surgery 152:1106-17
Vourganti, Srinivas; Rastinehad, Ardeshir; Yerram, Nitin et al. (2012) Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 188:2152-2157
Shuch, Brian; Bratslavsky, Gennady; Shih, Joanna et al. (2012) Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int 109:1600-6
Mena, Esther; Turkbey, Baris; Mani, Haresh et al. (2012) 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med 53:538-45
Eisenhofer, G; Vocke, C D; Elkahloun, A et al. (2012) Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution. Horm Metab Res 44:343-8

Showing the most recent 10 out of 29 publications